Results

Total Results: 1,653 records

Showing results for "described".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
    October 19, 2020 - While sarcopenic obesity has been described in hospitalized patients, most screening tools do not capture … daily living, quality of life, readmission, hospital acquired conditions, and discharge disposition as described
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
    October 12, 2016 - We mentioned in our list of study limitations that many interventions described as n-3 FA (especially … In my opinion details and characteristics are more than sufficient, and very clearly described, once … The Gustafson study was described narratively in the section on cognitive outcomes, although one domain … TEP Reviewer #4 Results In general results present enough detail and studies are clearly described … TEP Reviewer #4 Discussion/Conclusion Limitations are well described and implications of the major
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
    April 09, 2025 - Concerns about this are further described below. … TEP Reviewer 1 Discussion As described above, there may be important lessons that are missed because … We described our approach to doing this in the paragraph that starts on page 33, line 34. … the ERIC/EPOC taxonomies that were utilized to classify the implementation strategies that were described … Clinical practice implications and limitations are well described. Thank you for your comment.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
    October 01, 2014 - We found three published studies that described use of bone scans to evaluate treatment of metastatic … We identified four published studies9,15,16,20 that described use of MRI to evaluate treatment of metastatic … use of FDG,10,11,14-17,20,21,23,24 four described FLT,12,13,18,22 one described F-FMISO,11 and two … described FES19,20 (two studies evaluated more than one kind of tracer). … PET scans conducted 1990-1994 using tracer MET, now obsolete (1) Described diagnostic breast imaging
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
    August 27, 2012 - Perhaps in sections within the ES and the Full Report where disparities indicators are described. … We have removed the names of the RCTs; they are described in the Full Report. … TEP #2 Methods Conditions: same problems as described for Executive Summary. … TEP #3 Discussion/ Conclusion The limitations are described adequately. … We have ordered the interventions as described above.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - However, the Two- Question screen is not mentioned/described immediately before or after Table A. … Peer Reviewer 1 Results Yes, the studies are described with clarity and enough detail. … TEP Member 2 Results The studies were described well for the intevention- --impact of screening but less … They were well described for the "setting" quesiton. … The methodology is clearly described and of the highest quality.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methodological-recommendations-framework-communications_research.pdf
    September 01, 2013 - It comprises a series of four steps described in the following sections. … Further, as described next, it is preferable to avoid recommendations that mix together testable and … explicit description. 13 the presence of publication bias (and assuming the generative story described
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - 4 months with no change in pain intensity or function.13 • Two studies in the systematic reviews described … We did find a third systematic review that described mobile applications for opioid use disorder (presence … development of the applications and incorporation of features that were not evidence-based or fully described … local experts with expertise in pain management and opioid tapering, in order to assess the criteria described
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - 4 months with no change in pain intensity or function.13 • Two studies in the systematic reviews described … We did find a third systematic review that described mobile applications for opioid use disorder (presence … development of the applications and incorporation of features that were not evidence-based or fully described … local experts with expertise in pain management and opioid tapering, in order to assess the criteria described
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
    March 31, 2025 - Each study measured and described breastfeeding differently and used different comparisons for analyses … The focus of this report and the population of interest (as described in Table 1) is term infants. … Each health outcome is further described in terms of each study characteristic both from existing systematic … You have already described the limitations previously. … While a number of characteristics were described for each study, additional details (such as measurement
  11. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/outcome-research-white-paper.pdf
    June 01, 2022 - The rationale for the selection of these measures and the measure definitions are described in a separate … The work described in Chapter 2 focused on ensuring that the data elements necessary to calculate the … The registries work with the same technical vendor, and the data quality steps described below are the … These efforts and the resulting tools are described further below. … Both products are described further below.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_executive.pdf
    April 01, 2015 - In addition, PPH may be described as third or fourth stage depending on whether it occurs before or … context of the population, intervention, comparator, outcomes, timing, and setting (PICOTS) parameters described … for Healthcare Research and Quality standard of “good,” “fair,” and “poor” quality designations, as described … the observational data are biased and a single very large trial suggests that at least one clearly described … Management was not well described in many studies, especially for women who transferred from other
  13. effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
    May 31, 2016 - We did include the type of studies described here as parallel- e.g., worksites that had existing OSH … Peer Reviewer #3 Discussion The major finding as clearly stated with limitations adequately described … Limitations well described. I am not aware of missing studies. … Peer Reviewer #5 Discussion The limitations are well described. … Similar (and sometimes better) results have been described for health promotion programs that were
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-child-interventions_research-protocol.pdf
    March 26, 2012 - Specific clinical interventions are described below. … Analytic Framework Figure 1 depicts the KQs within the context of the PICOS described in the previous … The steps that we will take to accomplish the literature review are described below. … To assess the risk of bias of studies, we will use criteria described in the AHRQ Methods Guide for … The grades of evidence that can be assigned are described in Table 4.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - not in use in the United States. 7 Study Selection Using the inclusion and exclusion criteria described … Risk-of-Bias Assessment of Individual Studies The included studies were assessed using the approach described … evaluate methodological quality, we applied criteria for each study type derived from core elements described … Evidence The strength of evidence for each Key Question and outcome was assessed using the approach described … studies in the meta-analyses, and reasons for excluding any studies that were not incorporated, are described
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_disposition-comments.pdf
    October 01, 2012 - the focus on quality improvement interventions is logical, the rationale for this is not adequately described … We have described our rationale for using the 2000 cutoff in the introduction and methods sections … As described, many of the pilot studies included in this report are health services interventions in … Are the characteristics of the studies clearly described? … The characteristics of the study are clear and well described.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicide-prevention_disposition-comments.pdf
    October 04, 2016 - More detail on how to overcome the barriers to data linkage that are described would be helpful. … The search strategies are explicitly described and appear to e logical. … Reviewer #3 Discussion/ conclusion The current obstacles to more effective data linkage are clearly described … What some of the potential benefits could be of better linkage could be more thoroughly described.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
    June 06, 2011 - questions (KQs) within the context of the PICO (population, interventions, comparators, and outcomes) described … We will evaluate the quality of individual studies using the approach described in the Methods Guide … methodological quality, we will apply criteria for each study type that are derived from the core elements described … Question The strength of evidence for each key question will be assessed by using the approach described
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
    January 01, 2019 - classification Yes Overall survival Hazard ratio Definitely no No protocol available and subgroup analyses described … Alliance] Age Yes Overall survival Hazard ratio Definitely no No protocol available and subgroup analyses described
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nonpharmacologic-treatment_research-protocol.pdf
    October 04, 2016 - considered for inclusion if they describe adverse events associated with thermoplasty that have not been described … asthma-control composite measures, asthma-exacerbation measures, and asthma-related quality of life, as described

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: